The FDA has approved Ixempra (ixabepilone), a new anti-cancer treatment, for use in patients with metastatic or locally advanced breast cancer who have not responded to certain other cancer drugs.
Product News
October 16, 2007
4:00 am
Merck announced that the FDA has granted Isentress (raltegravir) tablets accelerated approval for use in combination with other antiretroviral agents for the treatment of HIV-1 infection in treatment-experienced adult patients who have evidence of viral replication and HIV-1 strains resistant to multiple antiretroviral agents.
Product news
October 11, 2007
4:00 am
Boehringer Ingelheim Pharmaceuticals announced that the FDA has granted full approval of Aptivus (tipranavir) capsules.
Product news
September 27, 2007
4:00 am
Sanofi-Aventis and Bristol-Myers Squibb said the FDA Administration has approved a supplemental new drug application for a 300 mg tablet of the antiplatelet drug Plavix (clopidogrel bisulfate).
Product news
September 25, 2007
4:00 am
GlaxoSmithKline announced that the European Commission has granted a marketing authorization for its cervical cancer vaccine, Cervarix, for all 27 European member states.
AZ/MedImmune’s FluMist gets big boost with new indication
MedImmune announced that the FDA has approved the use of its FluMist in children 2-5 years old, an indication that significantly expands the market for the nasal vaccine.
Product news
September 18, 2007
4:00 am
The FDA approved Eli Lillys osteoporosis drug Evista to reduce breast cancer risk in some postmenopausal women.
Product news
September 11, 2007
4:00 am
Quinnova Pharmaceuticals announced the commercial launch of Tersi Foam, (2.25% selenium sulfide) for the treatment of seborrheic dermatitis and tinea versicolor of the skin.
Product news
September 4, 2007
4:00 am
The FDA has approved Evithrom (human thrombin), a blood-clotting protein used to help control bleeding during surgery.